首页> 外国专利> CEREBRAL INFARCTION SEQUELA MEDICINE

CEREBRAL INFARCTION SEQUELA MEDICINE

机译:脑梗死后遗症药物

摘要

PROBLEM TO BE SOLVED: To obtain a new cerebral infarction sequela medicine and a new poor circulation medicine.;SOLUTION: This cerebral infraction sequela medicine contains a ginkgo leaf extract as an active ingredient, and is effective for improving the cerebral infarction sequela such as consciousness disorder dyskinesia, speech disorder, aphasia, emotional disorder, thought disorder, sensory disturbance, dyskmnesia and abnormal posture. Further, the poor circulation medicine and an 'air conditioner disease' medicine as a modern disease each contains the ginkgo leaf extract as an active ingredient.;COPYRIGHT: (C)2003,JPO
机译:要解决的问题:获得新的脑梗塞后遗症药物和新的血液循环不良药物。;解决方案:此脑梗塞后遗症药物含有银杏叶提取物作为有效成分,对改善意识等脑梗塞后遗症有效运动障碍,语言障碍,失语,情绪障碍,思想障碍,感觉障碍,运动障碍和姿势异常。此外,循环不良的药物和作为现代疾病的“空调疾病”药物均含有银杏叶提取物作为有效成分。;版权所有:(C)2003,JPO

著录项

  • 公开/公告号JP2003095966A

    专利类型

  • 公开/公告日2003-04-03

    原文格式PDF

  • 申请/专利号JP20010296314

  • 发明设计人 MORIMASA TADAOMI;

    申请日2001-09-27

  • 分类号A61K35/78;A61K31/365;A61K31/7048;A61P25/28;

  • 国家 JP

  • 入库时间 2022-08-22 00:12:59

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号